North America Cancer Treatment Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2022

SKU ID :GIR-10458829 | Published Date: 06-Feb-2017 | No. of pages: 120
Table of Contents 1 Market Overview 1.1 Cancer Treatment Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Chemotherapy 1.2.2 Targeted Therapy 1.2.3 Immunotherapy (Biologic Therapy) 1.2.4 Hormonal Therapy 1.2.5 Others 1.3 Market Analysis by Applications 1.3.1 Blood Cancer 1.3.2 Breast Cancer 1.3.3 Gastrointestinal Cancer 1.3.4 Prostate Cancer 1.3.5 Respiratory/Lung Cancer 1.3.6 Other Cancers 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Mexico Status and Prospect (2012-2022) 1.4.3 Canada Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Roche 2.1.1 Profile 2.1.2 Cancer Treatment Drugs Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Roche News 2.2 Novartis 2.2.1 Profile 2.2.2 Cancer Treatment Drugs Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Novartis News 2.3 Celgene 2.3.1 Profile 2.3.2 Cancer Treatment Drugs Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Celgene News 2.4 Amgen 2.4.1 Profile 2.4.2 Cancer Treatment Drugs Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 Amgen News 2.5 Johnson & Johnson 2.5.1 Profile 2.5.2 Cancer Treatment Drugs Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.4 Business Overview 2.5.5 Johnson & Johnson News 2.6 Bristol-Myers Squibb 2.6.1 Profile 2.6.2 Cancer Treatment Drugs Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.4 Business Overview 2.6.5 Bristol-Myers Squibb News 2.7 Takeda 2.7.1 Profile 2.7.2 Cancer Treatment Drugs Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7.4 Business Overview 2.7.5 Takeda News 2.8 Eli Lilly 2.8.1 Profile 2.8.2 Cancer Treatment Drugs Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8.4 Business Overview 2.8.5 Eli Lilly News 2.9 Pfizer 2.9.1 Profile 2.9.2 Cancer Treatment Drugs Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9.4 Business Overview 2.9.5 Pfizer News 2.10 AstraZeneca 2.10.1 Profile 2.10.2 Cancer Treatment Drugs Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10.4 Business Overview 2.10.5 AstraZeneca News 2.11 Astellas 2.11.1 Profile 2.11.2 Cancer Treatment Drugs Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11.4 Business Overview 2.11.5 Astellas News 2.12 Sanofi 2.12.1 Profile 2.12.2 Cancer Treatment Drugs Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12.4 Business Overview 2.12.5 Sanofi News 2.13 Bayer 2.13.1 Profile 2.13.2 Cancer Treatment Drugs Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13.4 Business Overview 2.13.5 Bayer News 2.14 Merck & Co. 2.14.1 Profile 2.14.2 Cancer Treatment Drugs Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14.4 Business Overview 2.14.5 Merck & Co. News 2.15 Biogen Idec 2.15.1 Profile 2.15.2 Cancer Treatment Drugs Type and Applications 2.15.2.1 Type 1 .2.2 Type 2 2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15.4 Business Overview 2.15.5 Biogen Idec News 2.16 Kyowa Hakko Kirin 2.16.1 Profile 2.16.2 Cancer Treatment Drugs Type and Applications 2.16.2.1 Type 1 2.16.2.2 Type 2 2.16.3 Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16.4 Business Overview 2.16.5 Kyowa Hakko Kirin News 2.17 Otsuka 2.17.1 Profile 2.17.2 Cancer Treatment Drugs Type and Applications 2.17.2.1 Type 1 2.17.2.2 Type 2 2.17.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17.4 Business Overview 2.17.5 Otsuka News 2.18 Teva 2.18.1 Profile 2.18.2 Cancer Treatment Drugs Type and Applications 2.18.2.1 Type 1 2.18.2.2 Type 2 2.18.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18.4 Business Overview 2.18.5 Teva News 2.19 Eisai 2.19.1 Profile 2.19.2 Cancer Treatment Drugs Type and Applications 2.19.2.1 Type 1 2.19.2.2 Type 2 2.19.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19.4 Business Overview 2.19.5 Eisai News 2.20 Merck KGaA 2.20.1 Profile 2.20.2 Cancer Treatment Drugs Type and Applications 2.20.2.1 Type 1 2.20.2.2 Type 2 2.20.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20.4 Business Overview 2.20.5 Merck KGaA News 2.21 Ipsen 2.21.1 Profile 2.21.2 Cancer Treatment Drugs Type and Applications 2.21.2.1 Type 1 2.21.2.2 Type 2 2.21.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21.4 Business Overview 2.21.5 Ipsen News 2.22 AbbVie 2.22.1 Profile 2.22.2 Cancer Treatment Drugs Type and Applications 2.22.2.1 Type 1 2.22.2.2 Type 2 2.22.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.22.4 Business Overview 2.22.5 AbbVie News 2.23 Gilead Sciences 2.23.1 Profile 2.23.2 Cancer Treatment Drugs Type and Applications 2.23.2.1 Type 1 2.23.2.2 Type 2 2.23.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.23.4 Business Overview 2.23.5 Gilead Sciences News 3 North America Cancer Treatment Drugs Market Competition, by Manufacturer 3.1 North America Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017) 3.2 North America Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017) 3.3 North America Cancer Treatment Drugs Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share 3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share 3.5 Market Competition Trend 4 North America Cancer Treatment Drugs Market Analysis by Countries 4.1 North America Cancer Treatment Drugs Sales Market Share by Countries 4.2 North America Cancer Treatment Drugs Sales by Countries (2012-2017) 4.3 North America Cancer Treatment Drugs Revenue (Value) by Countries (2012-2017) 5 North America Market Segmentation Cancer Treatment Drugs by Type 5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017) 5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Type (2012-2017) 5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017) 5.2 Chemotherapy Sales Growth and Price 5.2.1 North America Chemotherapy Sales Growth (2012-2017) 5.2.2 North America Chemotherapy Price (2012-2017) 5.3 Targeted Therapy Sales Growth and Price 5.3.1 North America Targeted Therapy Sales Growth (2012-2017) 5.3.2 North America Targeted Therapy Price (2012-2017) 5.4 Immunotherapy (Biologic Therapy) Sales Growth and Price 5.4.1 North America Immunotherapy (Biologic Therapy) Sales Growth (2012-2017) 5.4.2 North America Immunotherapy (Biologic Therapy) Price (2012-2017) 5.5 Hormonal Therapy Sales Growth and Price 5.5.1 North America Hormonal Therapy Sales Growth (2012-2017) 5.5.2 North America Hormonal Therapy Price (2012-2017) 5.6 Others Sales Growth and Price 5.6.1 North America Others Sales Growth (2012-2017) 5.6.2 North America Others Price (2012-2017) 6 North America Market Segmentation Cancer Treatment Drugs by Application 6.1 North America Cancer Treatment Drugs Sales Market Share by Application (2012-2017) 6.2 Blood Cancer Sales Growth (2012-2017) 6.3 Breast Cancer Sales Growth (2012-2017) 6.4 Gastrointestinal Cancer Sales Growth (2012-2017) 6.5 Prostate Cancer Sales Growth (2012-2017) 6.6 Respiratory/Lung Cancer Sales Growth (2012-2017) 6.7 Other Cancers Sales Growth (2012-2017) 7 United States Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers 7.1 United States Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017) 7.2 United States Cancer Treatment Drugs Sales and Market Share by Type 7.3 United States Cancer Treatment Drugs Sales by Application (2012-2017) 7.4 United States Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer 7.4.1 United States Cancer Treatment Drugs Sales and Market Share by Manufacturer 7.4.2 United States Cancer Treatment Drugs Revenue and Market Share by Manufacturer 7.5 United States Cancer Treatment Drugs Export and Import (2012-2017) 8 Canada Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers 8.1 Canada Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017) 8.2 Canada Cancer Treatment Drugs Sales and Market Share by Type 8.3 Canada Cancer Treatment Drugs Sales by Application (2012-2017) 8.4 Canada Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer 8.4.1 Canada Cancer Treatment Drugs Sales and Market Share by Manufacturer 8.4.2 Canada Cancer Treatment Drugs Revenue and Market Share by Manufacturer 8.5 Canada Cancer Treatment Drugs Export and Import (2012-2017) 9 Mexico Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers 9.1 Mexico Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017) 9.2 Mexico Cancer Treatment Drugs Sales and Market Share by Type 9.3 Mexico Cancer Treatment Drugs Sales by Application (2012-2017) 9.4 Mexico Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer 9.4.1 Mexico Cancer Treatment Drugs Sales and Market Share by Manufacturer 9.4.2 Mexico Cancer Treatment Drugs Revenue and Market Share by Manufacturer 9.5 Mexico Cancer Treatment Drugs Export and Import (2012-2017) 10 Cancer Treatment Drugs Market Forecast (2017-2022) 10.1 North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022) 10.2 Cancer Treatment Drugs Market Forecast by Countries (2017-2022) 10.2.1 United States Cancer Treatment Drugs Forecast (2017-2022) 10.2.2 Canada Cancer Treatment Drugs Forecast (2017-2022) 10.2.3 Mexico Cancer Treatment Drugs Forecast (2017-2022) 10.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022) 10.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022) 11 Cancer Treatment Drugs Manufacturing Cost Analysis 11.1 Cancer Treatment Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Cancer Treatment Drugs 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Cancer Treatment Drugs Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016 12.4 Downstream Buyers 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source
List of Tables and Figures Figure Cancer Treatment Drugs Picture Table Product Specifications of Cancer Treatment Drugs Figure North America Sales Market Share of Cancer Treatment Drugs by Types in 2016 Table Types of Cancer Treatment Drugs Figure Chemotherapy Picture Table Major Manufacturers of Chemotherapy Figure Targeted Therapy Picture Table Major Manufacturers of Targeted Therapy Figure Immunotherapy (Biologic Therapy) Picture Table Major Manufacturers of Immunotherapy (Biologic Therapy) Figure Hormonal Therapy Picture Table Major Manufacturers of Hormonal Therapy Figure Others Picture Table Major Manufacturers of Others Table North America Cancer Treatment Drugs Sales Market Share by Applications in 2016 Table Applications of Cancer Treatment Drugs Figure Blood Cancer Picture Figure Breast Cancer Picture Figure Gastrointestinal Cancer Picture Figure Prostate Cancer Picture Figure Respiratory/Lung Cancer Picture Figure Other Cancers Picture Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Mexico Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Canada Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Cancer Treatment Drugs Type and Applications Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Cancer Treatment Drugs Type and Applications Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celgene Basic Information, Manufacturing Base and Competitors Table Celgene Cancer Treatment Drugs Type and Applications Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Cancer Treatment Drugs Type and Applications Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Cancer Treatment Drugs Type and Applications Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takeda Basic Information, Manufacturing Base and Competitors Table Takeda Cancer Treatment Drugs Type and Applications Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Cancer Treatment Drugs Type and Applications Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Cancer Treatment Drugs Type and Applications Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Cancer Treatment Drugs Type and Applications Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Astellas Basic Information, Manufacturing Base and Competitors Table Astellas Cancer Treatment Drugs Type and Applications Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Cancer Treatment Drugs Type and Applications Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer Basic Information, Manufacturing Base and Competitors Table Bayer Cancer Treatment Drugs Type and Applications Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck & Co. Basic Information, Manufacturing Base and Competitors Table Merck & Co. Cancer Treatment Drugs Type and Applications Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biogen Idec Basic Information, Manufacturing Base and Competitors Table Biogen Idec Cancer Treatment Drugs Type and Applications Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors Table Kyowa Hakko Kirin Cancer Treatment Drugs Type and Applications Table Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Otsuka Basic Information, Manufacturing Base and Competitors Table Otsuka Cancer Treatment Drugs Type and Applications Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Basic Information, Manufacturing Base and Competitors Table Teva Cancer Treatment Drugs Type and Applications Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eisai Basic Information, Manufacturing Base and Competitors Table Eisai Cancer Treatment Drugs Type and Applications Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck KGaA Basic Information, Manufacturing Base and Competitors Table Merck KGaA Cancer Treatment Drugs Type and Applications Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Ipsen Basic Information, Manufacturing Base and Competitors Table Ipsen Cancer Treatment Drugs Type and Applications Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Cancer Treatment Drugs Type and Applications Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Gilead Sciences Basic Information, Manufacturing Base and Competitors Table Gilead Sciences Cancer Treatment Drugs Type and Applications Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table North America Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table North America Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table North America Cancer Treatment Drugs Price by Manufacturers (2016-2017) Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2016 Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017 Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2016 Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2017 Figure North America Cancer Treatment Drugs Sales and Growth (2012-2017) Table North America Cancer Treatment Drugs Sales by Countries (2012-2017) Table North America Cancer Treatment Drugs Sales Market Share by Countries (2012-2017) Figure North America 2012 Cancer Treatment Drugs Sales Market Share by Countries Figure North America 2016 Cancer Treatment Drugs Sales Market Share by Countries Figure North America Cancer Treatment Drugs Revenue and Growth (2012-2017) Table North America Cancer Treatment Drugs Revenue by Countries (2012-2017) Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017) Table North America 2012 Cancer Treatment Drugs Revenue Market Share by Countries Table North America 2016 Cancer Treatment Drugs Revenue Market Share by Countries Table North America Cancer Treatment Drugs Sales by Type (2012-2017) Table North America Cancer Treatment Drugs Sales Share by Type (2012-2017) Table North America Cancer Treatment Drugs Revenue by Type (2012-2017) Table North America Cancer Treatment Drugs Revenue Share by Type (2012-2017) Figure North America Chemotherapy Sales Growth (2012-2017) Figure North America Chemotherapy Price (2012-2017) Figure North America Targeted Therapy Sales Growth (2012-2017) Figure North America Targeted Therapy Price (2012-2017) Figure North America Immunotherapy (Biologic Therapy) Sales Growth (2012-2017) Figure North America Immunotherapy (Biologic Therapy) Price (2012-2017) Figure North America Hormonal Therapy Sales Growth (2012-2017) Figure North America Hormonal Therapy Price (2012-2017) Figure North America Others Sales Growth (2012-2017) Figure North America Others Price (2012-2017) Table North America Cancer Treatment Drugs Sales by Application (2012-2017) Table North America Cancer Treatment Drugs Sales Share by Application (2012-2017) Figure North America Blood Cancer Sales Growth (2012-2017) Figure North America Breast Cancer Sales Growth (2012-2017) Figure North America Gastrointestinal Cancer Sales Growth (2012-2017) Figure North America Prostate Cancer Sales Growth (2012-2017) Figure North America Respiratory/Lung Cancer Sales Growth (2012-2017) Figure North America Other Cancers Sales Growth (2012-2017) Figure United States Cancer Treatment Drugs Revenue and Growth (2012-2017) Figure United States Cancer Treatment Drugs Sales and Growth (2012-2017) Table United States Cancer Treatment Drugs Sales by Type (2012-2017) Table United States Cancer Treatment Drugs Sales Market Share by Type (2012-2017) Table United States Cancer Treatment Drugs Sales by Application (2012-2017) Table United States Cancer Treatment Drugs Sales Market Share by Application (2012-2017) Table United States Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table United States Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table United States Cancer Treatment Drugs Export and Import (2012-2017) Figure Canada Cancer Treatment Drugs Revenue and Growth (2012-2017) Figure Canada Cancer Treatment Drugs Sales and Growth (2012-2017) Table Canada Cancer Treatment Drugs Sales by Type (2012-2017) Table Canada Cancer Treatment Drugs Sales Market Share by Type (2012-2017) Table Canada Cancer Treatment Drugs Sales by Application (2012-2017) Table Canada Cancer Treatment Drugs Sales Market Share by Application (2012-2017) Table Canada Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table Canada Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table Canada Cancer Treatment Drugs Export and Import (2012-2017) Figure Mexico Cancer Treatment Drugs Revenue and Growth (2012-2017) Figure Mexico Cancer Treatment Drugs Sales and Growth (2012-2017) Table Mexico Cancer Treatment Drugs Sales by Type (2012-2017) Table Mexico Cancer Treatment Drugs Sales Market Share by Type (2012-2017) Table Mexico Cancer Treatment Drugs Sales by Application (2012-2017) Table Mexico Cancer Treatment Drugs Sales Market Share by Application (2012-2017) Table Mexico Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table Mexico Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table Mexico Cancer Treatment Drugs Export and Import (2012-2017) Figure North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022) Table North America Cancer Treatment Drugs Sales Forecast by Countries (2017-2022) Table North America Cancer Treatment Drugs Market Share Forecast by Countries (2017-2022) Figure United States Cancer Treatment Drugs Sales Forecast (2017-2022) Figure Canada Cancer Treatment Drugs Sales Forecast (2017-2022) Figure Mexico Cancer Treatment Drugs Sales Forecast (2017-2022) Table North America Cancer Treatment Drugs Sales Forecast by Type (2017-2022) Table North America Cancer Treatment Drugs Market Share Forecast by Type (2017-2022) Table North America Cancer Treatment Drugs Sales Forecast by Application (2017-2022) Table North America Cancer Treatment Drugs Market Share Forecast by Application (2017-2022) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Cancer Treatment Drugs Figure Manufacturing Process Analysis of Cancer Treatment Drugs Figure Cancer Treatment Drugs Industrial Chain Analysis Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016 Table Major Buyers of Cancer Treatment Drugs Table Distributors/Traders/ Dealers List
  • PRICE
  • $4480
    $8960

Our Clients